Association of the IGF1/pregnancy-associated plasma protein - A system and adipocytokine levels with the presence and the morphology of carotid plaques in type 2 diabetes mellitus patients with stable glycaemic control

European Journal of Endocrinology

Volumn 160, Issue 6, 2009, Pages 925-932

  Pellitero, Silvia ^a   Reverter, Jordi L ^a   Granada, María Luisa ^b   Pizarro, Eduardo ^c   Pastor, Cruz M ^b   Tàssies, Dolors ^d   Reverter, Juan Carlos ^d   Salinas, Isabel ^a   Sanmarti, Anna ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c Hospital of Mataro   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADIPOCYTOKINE; ADIPONECTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; FIBRINOGEN; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; PLASMINOGEN ACTIVATOR INHIBITOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOMATOMEDIN C; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PLAQUE FORMING CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD; CAROTID ARTERY DISEASE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY;

ADIPOKINES; AGED; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A;

EID: 66149120181     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0097     Document Type: Article

References (32)

1. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC & Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000 321 405-412.
2. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Jaff M, Kownator S, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F & Zureik M. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4thWatching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium. Cerebrovascular Diseases 2004 23 75-80.
3. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL & Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. New England Journal of Medicine 1999 340 14-22.
4. Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M, Nicolaides AN, Dhanjil S, Griffin M, Belcaro G, Rumley A & Lowe GD. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 1999 30 841-850.
5. Wyman RA, Fraizer MC, Keevil JG, Busse KL, Aeschlimann SE, Korcarz CE & Stein JH. Ultrasound-detected carotid plaque as a screening tool for advanced subclinical atherosclerosis. American Heart Journal 2005 150 1081-1085.
6. Nordestgaard BG, Grõnholdt ML & Sillesen H. Echolucent rupture-prone plaques. Current Opinion in Lipidology 2003 14 505-512.
7. Grønholdt ML, Nordestgaard BG, Schroeder TV, Vorstrup S & Sillesen H. Ultrasonic echolucent carotid plaques predict future strokes. Circulation 2001 104 68-73.
8. Bayés-Genis A, Conover CA & Schwartz RS. The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circulation Research 2000 86 125-130.
9. Bayés-Genis A, Conover CA, Overgaard MT, Bailey KR, Christiansen M, Holmes DR, Virmani R, Oxvig C & Schwartz RS. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. New England Journal of Medicine 2001 345 1022-1029.
10. Cosin-Sales J, Kaski JC, Christiansen M, Kaminski P, Oxvig C, Overgaard MT, Cole D & Holt DW. Relationship among PAPP-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. European Heart Journal 2005 26 2093-2098.
11. Conti E, Andreotti F & Zuppi C. Pregnancy-associated plasma protein-A as predictor of outcome in patients with suspected acute coronary syndromes. Circulation 2005 109 e211-e212.
12. Crea F & Andreotti F. Pregnancy associated plasma protein-A and coronary atherosclerosis: marker, friend, or foe? European Heart Journal 2005 26 2075-2076.
13. Piñon P & Kaski JC. Inflammation, atherosclerosis and cardiovascular disease risk: PAPP-A, Lp-PLA2 and cystatin C, New insights or redundant information? Revista Española de Cardiología 2006 59 247-258.
14. Cosin-Sales J, Christiansen M, Kaminski P, Oxvig C, Overgaard MT, Cole D, Holt DW & Kaski JC. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 2004 109 1724-1728.
15. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Simoons ML & Zeiher AM. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes. Comparison with markers of systemic inflammation, platelet activation, andmyocardialnecrosis. Journal of the American College of Cardiology 2005 45 229-237.
16. Lund J, Qin QP, Ilva T, Pettersson K, Voipio-Pulkki LM, Porela P & Pulkki K. Circulating pregnancy-associated plasma protein A (PAPP-A) predicts outcome in patients with acute coronary syndromesbut no troponin I elevation. Circulation 2003 108 1924-1926.
17. Conti E, Carrozza C, Capoluongo E, Volpe M, Crea F, Zuppi C & Andreotti F. Insulin like growth factor-1 as a vascular protective factor. Circulation 2004 110 2260-2265.
18. Beaudeux JL, Burc L, Imbert-Bismut F, Giral P, Bernard M, Bruckert E & Chapman MJ. Serum plasma pregnancy-associated protein A: a potential marker of echogenic carotid atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular risk. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 e7-e10.
19. Sangiorgi G, Mauriello A, Bonanno E, Oxvig C, Conover CA, Christiansen M, Trimarchi S, Rampold V, Holmes DR Jr, Schwartz RS & Spagnoli LG. Pregnancy-associated plasma protein-A is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events. Journal of the American College of Cardiology 2006 47 2201-2211.
20. Janssen JA & Lamberts SW. The role of IGF1 in the development of cardiovascular disease in type 2 diabetes mellitus: is prevention possible? European Journal of Endocrinology 2002 146 467-477.
21. Juul A, Scheike T, Davidsen M, Gyllenborg J & Jørgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002 106 939-944.
22. Laughlin GA, Barrett-Connor E, Criqui MH & Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF1) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. Journal of Clinical Endocrinology and Metabolism 2004 89 114-120.
23. Colao A, Di Somma C, Spiezia S, Savastano S, Rota F, Savanelli MC & Lombardi G. Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 2008 93 3416-3424.
24. Martin RM, Gunnell D, Whitley E, Nicolaides A, Griffin M, Georgiou N, Davey Smith G, Ebrahim S & Holly JM. Associations of insulin-like growth factor (IGF)-I, IGF1I, IGF binding protein (IGFBP)-2 and IGFBP-3 with ultrasound measures of atherosclerosis and plaque stability in an older adult population. Journal of Clinical Endocrinology and Metabolism 2008 93 1331-1338.
25. Kolaczynski JW & Caro JF. Insulin-like growth factor-1 therapy in diabetes: physiologic basis, clinical benefits, and risks. Annals of Internal Medicine 1994 120 47-55.
26. Pellitero S, Reverter JL, Pizarro E, Pastor MC, Granada ML, Tàssies D, Reverter JC, Salinas I & Sanmarti A. Pregnancy-associated plasma protein-A levels are related to glycaemic control but not to lipid profile or hemostatic parameters in type 2 diabetes mellitus. Diabetes Care 2007 30 3083-3085.
27. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004 27 S5-S10.
28. Mueller T, Dieplinger B, Poelz W & Haltmayer M. Increased pregnancy-associated plasma protein-A as a marker for peripheral atherosclerosis: results from the Linz Peripheral Arterial Disease Study. Clinical Chemistry 2006 52 1096-2103.
29. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB & Vasan RS. Multiple biomarkers for the prediction of first major cardiovascular events and death. New England Journal of Medicine 2006 355 2631-2639.
30. Aso Y, Okumura K, Wakabayashi S, Takebayashi K, Taki S & Inukai T. Elevated pregnancy-associated plasma protein-A in sera from type 2 diabetic patients with hypercholesterolemia: associations with carotid atherosclerosis and toe-brachial index. Journal of Clinical Endocrinology and Metabolism 2004 89 5713-5717.
31. Stulc T, Malbohan I, Malik J, Fialova L, Soukupova J & Ceska R. Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatment. American Heart Journal 2003 146 e21.
32. Qin QP, Kokkala S, Lund J, Tamm N, Qin X, Lepantalo M & Pettersson K. Immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes. Clinical Chemistry 2006 52 398-404.